Duality Advisers, LP
- SEC CIK
- 0001741024
- Latest filing
- Nov 14, 2025
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by Duality Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q3 2025 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −10,676−100.0% | Sold out | Holders |
| Q2 2023 | 10,676 | $380.7K | <0.1% | −10,020−48.4% | Reduced | Holders |
| Q1 2023 | 20,696 | $525.7K | 0.1% | +20,696 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −56,917−100.0% | Sold out | Holders |
| Q3 2022 | 56,917 | $1.88M | 0.2% | +15,102+36.1% | Added | Holders |
| Q2 2022 | 41,815 | $1.47M | 0.1% | +29,564+241.3% | Added | Holders |
| Q1 2022 | 12,251 | $563.0K | 0.1% | +12,251 | New | Holders |